In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity

Immune checkpoint blockade (ICB) therapy potently revives T cell's response to cancer. However, patients suffered with tumors that had inadequate infiltrated immune cells only receive limited therapeutic benefits from ICB therapy. Synthetic biology promotes the alternative strategy of harnessin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhongda, Meng, Fanqiang, Ma, Yumeng, Zhang, Chi, Zhang, Zhirang, Yang, Zhaoxin, Li, Yuan, Hou, Linlin, Xu, Yuzhong, Liang, Xin, Zhang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542607/
https://www.ncbi.nlm.nih.gov/pubmed/37790917
http://dx.doi.org/10.1016/j.bioactmat.2023.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542607/
https://www.ncbi.nlm.nih.gov/pubmed/37790917
http://dx.doi.org/10.1016/j.bioactmat.2023.09.007

Ejemplares similares